Andilab, Heidelyn .
HRN: 16-95-54 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/21/2025
CEFUROXIME 500MG (TAB)
06/21/2025
06/28/2025
ORAL
500 MG/TAB
BID
S/P NSVD, THINLY MSAF
Checking Initial Appropriateness